Consolidated Statements of Cashflows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Cash Flows from Operating Activities:
Net loss	$ (254,336)	$ (1,030,331)
Net loss to net cash used in operating activities:
Stock based compensation	285,338	84,440
Stock based finance incentive		379,814
Forfeit of restricted stock units	(659,052)
Loss on change in fair value of warrant derivative liability	72,519	23,891
Amortization of debt discount		22,429
Amortization of intangible asset	56,521	101,193
Depreciation	3,106	4,223
Changes in operating assets and liabilities:
Decrease in accounts receivable	3,778	2,581
Increase (decrease) in accrued liabilities	(3,156)	10,985
Increase (decrease) in accounts payable	336,901	(3,523)
Net cash used in operating activities	(158,381)	(404,298)
Cash flows from investing activities
Purchase of intangible assets	(11,138)	(11,684)
Net cash used in investing activities	(11,138)	(11,684)
Cash flows from financing activities
Repayment of loans payable	(2,430)	(3,322)	$ (3,322)
Repayment of loans payable - related party	(18,228)	(52,556)
Proceeds from loans payable - related party	223,777	19,709
Net proceeds from issuance of Series C Preferred stock		421,000
Proceeds from issuance of convertible notes payable		15,000
Net cash provided by financing activities	203,119	399,831
Effects of exchange rate changes on cash	(31,018)	46,676
Net Change in Cash	2,582	30,525
Cash - Beginning of Period	32,533	62,967	62,967
Cash - End of Period	35,115	93,492	$ 32,533
Supplemental information:
Cash paid for interest	4,774	5,712
Cash paid for taxes
Non-cash investing and financing activities
Warrant liability		449,043
Declared dividends	21,672	3,272
Common stock issued in satisfaction of dividend payable	$ 22,133